Haematology Flashcards

(68 cards)

1
Q

acute lymphoblastic leukaemia prevalence

A

most common cancer in paeds
2-5 yrs
males more
trisomy 21 increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

acute lymphoblastic leukaemia pathop

A

infection, genetic + environment
disruptions in regulation and proliferation of lymphoid precursor cells in bone marrow…excessive production of blast cells, drop in R.B.C, W.B.C and platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

history ALL

A

anaemia - lethargy
thrombocytopenia - bruising
leukopenia - infection
bone pain
weight loss
malaise
headache
seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

examination ALL

A

pale
excess bruising/bleeding
lymphadenopathy
hepatosplenomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ddx ALL

A

immune thrombocytopenia, immune deficiency, reactive lymphodenopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

investigations ALL

A

FBC - pancytopenia, anaemia, thrombocytopenia
blood film - blast cells
CXR - mediastinal mass
bone marrow aspirate
LP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

risk scoring ALL

A

1-10 yrs - better prognosis
WCC>50 - poorer
females - better
blasts within CSF - poorer
morphology and cytology - effects prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

immediate management ALL

A

resus - high WCC requires hyperhydration to prevent hyperviscosity
if mediastinus mass - steroids
if infection - abx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

definitive ALL

A

chemo - IV, PO, intrathecally
blood products and prophylactic anti-fungal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

prognosis ALL

A

over 90% survive
follow up for 5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

complications ALL

A

infertility
avascular necrosis
peripheral neuropathy
anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

2 types of acute leukaemia

A

acute lymphoblastic leukaemia (maj)
acute myeloid leukaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

acute leukaemia pathophysiology

A

blood stem cell - can be lymphoid stem cell or myeloid stem cell
lymphoid - WBC
myeloid - RBC, WBC, platelets

genetic mutations in blood progenitor cells…causes developmental arrest…causing immature cells (myeloblasts) - less healthy cells…infection, anaemia, bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

childhood AML diagnosis

A

when bone marrow has 20% or more blasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

classification AML

A

FAB classification
MO-M7
morphological and histochemical characteristics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

leukaemia cells spread

A

to CNS, skin and gyms
can form solid tumour called chloroma or granylocytic sarcoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

risk factors AML

A

Down’s syndrome
Li-Fraumeni Syndrome
Aplastic anaemia
Myelodysplasia
Affected sibling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

3 main pathological processes acute leukaemia

A

bone marrow failure due to infiltration by blasts
blast infiltration of other tissues
systemic effects of cytokines released by leukaemic cells and of increased plasma viscosity (leucostasis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

acute leukaemia investigations

A

FBC- pancytopenia, neutropenic
blood film - blasts, atypical cells, leukoerythroblastic features
CXR - lymph gland enlargement
bone marrow aspirate - definitive diagnosis
LP
biopsy of chloroma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

acute leukaemia bone marrow exam

A

aspirate - response to chemo and risk of relapse
light microscopy - classification
immunophenotyping - identify subtype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

initial management acute leukaemia

A

IV chemo - induction (2 cycles 4 weeks apart) and post remission consolidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

long term managent acute leukaemia

A

post remission therapy - further chemo
and/or allogeneic haematopoeitic stem cell transplantation
bone marrow transplant - if chemo not work or relapses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

complications acute leukaemia

A

neutropenic sepsis
myelosuppression
N+V
mucositis
hair loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

chemo agent and side effect AML

A

Doxorubicin Cardiotoxicitiy
Vincristine Peripheral neuropathy
Cyclophosphamide Reduced fertility
Cytarabine Hepatotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
prognosis AML
5 year survival of 66% if poor cytogenic features or response to therapy - <20% cured
26
haemophilia genetics
x linked recessive more common in males
27
haemophilia A v B
A - factor VIII (more common) B - factor IX
28
pathophysiology haemophilia
factor VIII is one of main clotting factors that contibutes to production of thrombin via intrinsic pathway. The intrinsic pathway is activated in response to endothelial collagen exposure...therefore lack of favot VIII...deficient in thrombin...results in insufficient production of fibrin for clot stabilisation
29
severity of haemophilia A
depends on plasma conc of factor VIII if severe, may have no measurable factor in blood
30
risk factors haemophilia
male family hx
31
hx haemophilia
prolonged, unexplained bleeding recurrent episodes spontaneous bleeding joint pain, swelling, reduced ROM - haemarthrosis
32
examination haemophilia
active bleeding pallor bruising haemarthrosis
33
haemophilia ddx
non accidental injury (social care) von willebrand disease vit K deficiency ALL
34
investigations haemophilia
FBC - anaemia coagulation screen - prolonged APTT, normal PT, factor will be low CT head, joint aspiration - additional
35
management haemophilia
treating bleeds - in: one off infusion of factor prophylaxis - regular IV infusion of factor education avoid contact sports good dental hygeine
36
complications haemophilia
chronic arthopathy development of factor VIII or IX inhibitors transfusion related complications
37
lymphoma types
hodgkin and non hodgkin lymphoma
38
epidemiology lymphoma
over 10% of childhood cancers on boys older children
39
pathophysiology lymphoma
multifactorial adults - obesity, smoking, alcohol
40
history lymphoma
EMV immunosuppresed - transplant, previous cancers weight loss, night sweats, fevers
41
examination lymphoma
non tender lymphadenopathy if mediastinus - wheeze, difficulty breathing SVC obstruction
42
ddx lymphoma
reactive lymphadenopathy leukaemia met malignancy
43
investigations lymphoma
FBC UE - tumour lysis syndrome can cocur before tx begins LDH - elevated USS of area and nodes and biopsy CXR - mediastinal nodes full body CT lymph node biopsy
44
risk scoring lymphoma
1 - single group of nodes or organ 2 - 2 or more groups of nodes or organs on same side of diaphragm 3 - in lymph nodes or organs on both sides 4 - diffuse involvement of nodes and organs such as liver and bones B added to stage if B symptoms present - weight loss, night swats, fevers
45
immediate management haemophilia
airway compromise high dose steroids SVCO may require stenting of veins hyperhydration in tumour lysis syndrome
46
definitive management lymphoma
chemo and possible radiotherapy, depending on stage
47
prognosis lymphoma
majority recover hodgkin's more favourable than non
48
complications lymphoma
tumour lysis syndrome, which is seen when rapid lysis of tumour cells causes release of large amounts of phosphorus, potassium and calcium leading to potential kidney damage. This is most likely to occur when chemotherapy is first commenced, but may occur beforehand neurotropenia alopecia sub fertility
49
genetics sickle cell
a mutation in the gene encoding the haemoglobin subunit β, encoded by the beta globin gene. It is inherited in an autosomal recessive
50
epidemiology sickle cell
1 in 2,449 in the UK with a carrier risk of 1 in 89 marked variation by region malarial hypothesis - survival advantage against malaria increasing prevalence of HbS allele in high income countries
51
pathophysiology sickle cell
The HbS allele results from a single nucleic acid substitution from GAG to GTG in the beta globin gene. This causes glutamic acid to be substituted with valine. Individuals with one HbS allele (HbAS) are carriers while those who are homozygous for the HbS allele (HbSS) have sickle cell disease. This is the most common type of sickle cell disease, however it is also possible to have one HbS allele and a different faulty beta globin allele other than HbS (such as β-thalassaemia, written as HbSβ-thalassaemia This makes it prone to sickling where it becomes rigid and distorts into crescent shape. in the deoxygenated state, HbS tetramers bind to each other and polymerise...vaso-occlusion and chronic haemolysis
52
risk factors sickle cell
black african, black caribbean - 1 in 200 affected, 1 in 10 carriers next common - asian lowest - white
53
sickle cells history
intermittent vaso-occlusive crises - severely painful, precipitated by hypoxia, infection, exercise, dehydration, acidosis dactylitis family history
54
examination sickle cell
Pallor, lethargy – due to anaemia Jaundice – due to haemolysis Fever Tachycardia, tachypnoea Digital redness, swelling and pain
55
ddx sickle cell
gout acute abdomen
56
vaso occulsive crisis >7 days
consider osteomyelitis or avascular necrosis
57
investigations sickle cell
haemoglobin electrophoresis - HbA absence high performance liquid chromatography blood film - nucleated red cells, howell jolly bodies, sickle shaped FBC and reticulocyte count iron studies X ray of long bones CXR - acute chest syndrome
58
screening sickle cell
antenatal screening - heel prick test
59
acute pain crisis sickle cell
analgesia fluid oxygen abx if infection
60
prophylactic tx sickle cell
Hydroxycarbamide – reduces frequency of painful crises Novel and experimental treatments – including L-glutamine, crizanlizumab and Voxelotor Regular blood transfusions – targeted to maintain HbS <30%
61
complications sickle cell
increased susceptibility to infection - pneumococcal and salmonellavac
62
vaccinations sickle cell
seasonal influenza vaccines – annual pneumococcal vaccines – every 5 years hepatitis B vaccine – if receiving regular blood transfusions other vaccines, such as meningococcal C or haemophilus influenza type B vaccine – may be advisable if they haven’t had them before
63
complications sickle cell
pulmonary hypertension leg ulcers priapism chronic kidney disease large-artery ischemic stroke
64
aplastic crisis
result from infection with parvovirus B19
65
prognosis sickle cell
median life expectancy is 58 years for HbSS and 66 years for HbSC and HbSbeta-thalassaemia life expectancy increasing infection or stroke - most common mortality acute chest syndrome - adults
66
poor prognostic factors sickle cell
earlier first presentation high frequency of vaso-occlusive crises
67
68